Telix Pharmaceuticals Ltd. (TLX)
8.96
+0.10
(+1.19%)
USD |
NASDAQ |
Nov 18, 16:00
8.955
0.00 (0.00%)
After-Hours: 20:00
Telix Pharmaceuticals Price : 8.96 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 9.00 | 9.051 | 8.90 | 8.96 | 418746.0 |
| Nov 17, 2026 | 8.99 | 9.025 | 8.84 | 8.855 | 249302.0 |
| Nov 16, 2026 | 9.12 | 9.16 | 8.92 | 8.92 | 225785.0 |
| Nov 13, 2026 | 9.34 | 9.34 | 9.175 | 9.23 | 110847.0 |
| Nov 12, 2026 | 9.48 | 9.48 | 9.27 | 9.36 | 251937.0 |
| Nov 11, 2026 | 9.63 | 9.77 | 9.56 | 9.725 | 285450.0 |
| Nov 10, 2026 | 9.57 | 9.57 | 9.36 | 9.45 | 161444.0 |
| Nov 09, 2026 | 9.75 | 9.96 | 9.64 | 9.89 | 405356.0 |
| Nov 06, 2026 | 9.42 | 9.71 | 9.42 | 9.63 | 311773.0 |
| Nov 05, 2026 | 9.74 | 9.87 | 9.37 | 9.42 | 328406.0 |
| Nov 04, 2026 | 9.43 | 9.69 | 9.36 | 9.67 | 531931.0 |
| Nov 03, 2026 | 9.05 | 9.09 | 9.00 | 9.03 | 174897.0 |
| Nov 02, 2026 | 9.17 | 9.175 | 9.03 | 9.05 | 258165.0 |
| Oct 30, 2026 | 9.26 | 9.26 | 8.98 | 9.10 | 341882.0 |
| Oct 29, 2026 | 9.55 | 9.60 | 9.48 | 9.51 | 211313.0 |
| Oct 28, 2026 | 9.21 | 9.285 | 9.131 | 9.26 | 244617.0 |
| Oct 27, 2026 | 8.94 | 9.06 | 8.91 | 9.03 | 224848.0 |
| Oct 26, 2026 | 9.00 | 9.01 | 8.91 | 8.99 | 323417.0 |
| Oct 23, 2026 | 9.26 | 9.295 | 9.11 | 9.15 | 413442.0 |
| Oct 22, 2026 | 9.56 | 9.605 | 9.43 | 9.54 | 734054.0 |
| Oct 21, 2026 | 10.25 | 10.25 | 9.92 | 10.03 | 879078.0 |
| Oct 20, 2026 | 10.98 | 11.24 | 10.98 | 11.16 | 304952.0 |
| Oct 19, 2026 | 10.71 | 10.85 | 10.68 | 10.74 | 249790.0 |
| Oct 16, 2026 | 10.92 | 10.94 | 10.66 | 10.69 | 324859.0 |
| Oct 15, 2026 | 10.52 | 10.59 | 10.43 | 10.57 | 220693.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Mesoblast Ltd. | 11.64 |
| Immutep Ltd. | 3.25 |
| CSL Ltd. | 32.90 |
| Ceryvyn Therapeutics Ltd. | 0.028 |
| Propanc Biopharma, Inc. | 1.76 |
Price Related Metrics
| PE Ratio | 95.83 |
| PS Ratio | 3.490 |
| Price to Book Value | 25.33 |
| Earnings Yield | 1.04% |
| Market Cap | 3.044B |
| Normalized PE Ratio | 164.10 |